Migration, psychosis and immune activation

Migration, psychosis and immune activation - Migration, psychosis and immune activation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35853

Enrollment

Registered

2012-02-22

Start date

2011-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis schizophrenia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: Group 1. 15 participants, born in or born from parents born in Morocco, Turkey, Surinam or the Netherlands Antilles, age at migration

Exclusion criteria

Exclusion criteria: Patients: Diagnosis of DSM IV substance induced psychotic disorder, mood disorder with psychotic features, delusional disorder, psychotic disorder NOS or psychotic disorder due to a somatic condition; IQ lower than 70.;Controls: History of psychotic disorder; IQ lower than 70.

Design outcomes

Primary

Measure	Time frame
Mean level of mRNA in monocytes and intracellular cytokines in T-cells.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results